Research has investigated the mechanisms of pulmonary fibrosis, with one study focusing on amiodarone-induced pulmonary fibrosis. Another study examined the modulation of fibrotic pathways by a specific plant, Swertia chirayita, in pulmonary fibrosis. A separate analysis explored the connection between anti-allergic drug targets and cardiovascular disease risk, although its direct relation to pulmonary fibrosis is unclear.